Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for patients suffering from rare diseases for which there are a lack of available treatment options.
Year founded2011
Served areaWorldwide
Headcount25
62,385,677
IPOJune 15, 2017
Stock exchange(s)Nasdaq Stockholm